The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles
Geoffrey B. Varty(Institute of Neurobiology), Rosalia Bertorelli(San Raffaele University of Rome), Guy A. Higgins, Annamarie J. Pond, Eric M. Parker(University of New Hampshire), Elisa Nicolussi(San Raffaele University of Rome), A Forlani(San Raffaele University of Rome), Donald H. Guthrie, Silva Fredduzzi(San Raffaele University of Rome), John C. Hunter, Robert A. Hodgson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sherry Lu, Angelo Reggiani(San Raffaele University of Rome), Michael E. Grzelak, Mariagrazia Grilli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)
Cited by 166
Related Papers
Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation
|Journal of Biological Chemistry|2004|716
Protein misfolding in neurodegenerative diseases: implications and strategies
|Translational Neurodegeneration|2017|671
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
|Journal of Pharmacology and Experimental Therapeutics|2015|336
Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells.
|Journal of Biological Chemistry|1991|283